Общедоступные статьи - Park Hae-SimПодробнее...
2 статьи недоступны нигде
Drug‐specific CD4+ T‐cell immune responses are responsible for antituberculosis drug‐induced maculopapular exanthema and drug reaction with eosinophilia …
YM Ye, GY Hur, SH Kim, GY Ban, YK Jee, DJ Naisbitt, HS Park, SH Kim
British Journal of Dermatology 176 (2), 378-386, 2017
Финансирование: UK Medical Research Council
Ranitidine-induced anaphylaxis with detection of serum specific IgE to ranitidine and human serum albumin conjugates
HJ Jin, JE Kim, YM Ye, YS Chang, HS Park
Annals of Allergy, Asthma & Immunology 108 (3), 210-212. e1, 2012
Финансирование: US National Institutes of Health
23 статьи доступны в некоторых источниках
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
JL Brożek, J Bousquet, I Agache, A Agarwal, C Bachert, ...
Journal of Allergy and Clinical Immunology 140 (4), 950-958, 2017
Финансирование: UK Medical Research Council
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation …
J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ...
Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020
Финансирование: UK Medical Research Council
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the …
I Agache, J Beltran, C Akdis, M Akdis, C Canelo‐Aybar, GW Canonica, ...
Allergy 75 (5), 1023-1042, 2020
Финансирование: Swiss National Science Foundation, European Commission, Innovation Fund Denmark
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ...
Allergy 70 (11), 1372-1392, 2015
Финансирование: UK Medical Research Council
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ...
Clinical and translational allergy 6 (1), 47, 2016
Финансирование: UK Medical Research Council, National Institute for Health Research, UK
2019 ARIA Care pathways for allergen immunotherapy
J Bousquet, O Pfaar, A Togias, HJ Schünemann, I Ansotegui, ...
Allergy 74 (11), 2087-2102, 2019
Финансирование: UK Medical Research Council
MASK 2017: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma multimorbidity using real‐world‐evidence
J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, ...
Clinical and translational allergy 8 (1), 45, 2018
Финансирование: UK Medical Research Council
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
ME Wechsler, LB Ford, JF Maspero, ID Pavord, A Papi, A Bourdin, H Watz, ...
The Lancet Respiratory Medicine 10 (1), 11-25, 2022
Финансирование: US National Institutes of Health, Patient-Centered Outcomes Research Institute
COVID-19, asthma, and biological therapies: what we need to know
M Morais-Almeida, R Aguiar, B Martin, IJ Ansotegui, M Ebisawa, ...
World Allergy Organization Journal 13 (5), 100126, 2020
Финансирование: US National Institutes of Health
Guidance to 2018 good practice: ARIA digitally‐enabled, integrated, person‐centred care for rhinitis and asthma
J Bousquet, A Bedbrook, W Czarlewski, GL Onorato, S Arnavielhe, ...
Clinical and translational allergy 9 (1), 16, 2019
Финансирование: American Heart Association
Next‐generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
JJ Bousquet, HJ Schünemann, A Togias, M Erhola, PW Hellings, ...
Clinical and translational allergy 9 (1), 44, 2019
Финансирование: US National Institutes of Health
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
J Bousquet, J Farrell, G Crooks, P Hellings, EH Bel, M Bewick, ...
Clinical and translational allergy 6 (1), 29, 2016
Финансирование: UK Medical Research Council, National Institute for Health Research, UK
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
M Jutel, I Agache, M Zemelka‐Wiacek, M Akdis, T Chivato, S Del Giacco, ...
Allergy 78 (11), 2851-2874, 2023
Финансирование: Swiss National Science Foundation
Viral infections and associated factors that promote acute exacerbations of asthma
CK Kim, Z Callaway, JE Gern
Allergy, asthma & immunology research 10 (1), 12-17, 2018
Финансирование: US National Institutes of Health
Current and future treatments of rhinitis and sinusitis
GB Patel, RC Kern, JA Bernstein, P Hae-Sim, AT Peters
The Journal of Allergy and Clinical Immunology: In Practice 8 (5), 1522-1531, 2020
Финансирование: US National Institutes of Health
Toward personalization of asthma treatment according to trigger factors
K Niespodziana, K Borochova, P Pazderova, T Schlederer, N Astafyeva, ...
Journal of Allergy and Clinical Immunology 145 (6), 1529-1534, 2020
Финансирование: Austrian Science Fund, UK Medical Research Council, National Institute for …
Treatable traits in the NOVELTY study
A Agustí, E Rapsomaniki, R Beasley, R Hughes, H Müllerová, A Papi, ...
Respirology 27 (11), 929-940, 2022
Финансирование: Government of Spain
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
J Bousquet, O Pfaar, I Agache, A Bedbrook, CA Akdis, GW Canonica, ...
Clinical and translational allergy 11 (4), e12014, 2021
Финансирование: Government of Spain
Информация о публикациях и финансировании собрана автоматически.